Valentina Kon
Last active: 3/19/2014


Dr. Kon's research focuses on the connections between chronic kidney disease (CKD) and cardiovascular disease. In particular, she had been interested in defining the mechanisms underlying CKD-associated dysfunctions of lipid handling and inflammatory functions by the macrophage, a key cell type in development and progression of atherosclerotic heart disease.


The following timeline graph is generated from all co-authored publications.

  1. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis. Yamamoto S, Yancey PG, Zuo Y, Ma LJ, Kaseda R, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V (2011) Arterioscler Thromb Vasc Biol 31(12): 2856-64
    › Primary publication · 21979434 (PubMed) · PMC3227118 (PubMed Central)
  2. Podocyte injury damages other podocytes. Matsusaka T, Sandgren E, Shintani A, Kon V, Pastan I, Fogo AB, Ichikawa I (2011) J Am Soc Nephrol 22(7): 1275-85
    › Primary publication · 21719786 (PubMed) · PMC3137575 (PubMed Central)
  3. Quantitative estimates of the variability of in vivo sonographic measurements of the mouse aorta for studies of abdominal aortic aneurysms and related arterial diseases. Sampson UK, Perati PR, Prins PA, Pham W, Liu Z, Harrell FE, Linton MF, Gore JC, Kon V, Fazio S (2011) J Ultrasound Med 30(6): 773-84
    › Primary publication · 21632991 (PubMed) · PMC3810347 (PubMed Central)
  4. Protective effects of PPARĪ³ agonist in acute nephrotic syndrome. Zuo Y, Yang HC, Potthoff SA, Najafian B, Kon V, Ma LJ, Fogo AB (2012) Nephrol Dial Transplant 27(1): 174-81
    › Primary publication · 21565943 (PubMed) · PMC3276311 (PubMed Central)
  5. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside. Ma J, Matsusaka T, Yang HC, Zhong J, Takagi N, Fogo AB, Kon V, Ichikawa I (2011) Pediatr Res 70(1): 83-9
    › Primary publication · 21451433 (PubMed) · PMC3113658 (PubMed Central)
  6. Angiotensin type 1 receptor modulates macrophage polarization and renal injury in obesity. Ma LJ, Corsa BA, Zhou J, Yang H, Li H, Tang YW, Babaev VR, Major AS, Linton MF, Fazio S, Hunley TE, Kon V, Fogo AB (2011) Am J Physiol Renal Physiol 300(5): F1203-13
    › Primary publication · 21367915 (PubMed) · PMC3094053 (PubMed Central)
  7. Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Yamamoto S, Zuo Y, Ma J, Yancey PG, Hunley TE, Motojima M, Fogo AB, Linton MF, Fazio S, Ichikawa I, Kon V (2011) Nephrol Dial Transplant 26(8): 2491-7
    › Primary publication · 21245127 (PubMed) · PMC3203394 (PubMed Central)
  8. Glomerular sclerosis is prevented during urinary tract obstruction due to podocyte protection. Matsusaka T, Kobayashi K, Kon V, Pastan I, Fogo AB, Ichikawa I (2011) Am J Physiol Renal Physiol 300(3): F792-800
    › Primary publication · 21177778 (PubMed) · PMC3064125 (PubMed Central)
  9. Atherosclerosis in chronic kidney disease: the role of macrophages. Kon V, Linton MF, Fazio S (2011) Nat Rev Nephrol 7(1): 45-54
    › Primary publication · 21102540 (PubMed) · PMC3810304 (PubMed Central)
  10. The glomerulus--a view from the inside--the endothelial cell. Fogo AB, Kon V (2010) Int J Biochem Cell Biol 42(9): 1388-97
    › Primary publication · 20541032 (PubMed)